Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease

Neurobiology of Disease

Volumn 54, Issue , 2013, Pages 59-67

  Grand'Maison, Marilyn ^a   Zehntner, Simone P ^b   Ho, Ming Kai ^a   Hébert, François ^b   Wood, Andrew ^b   Carbonell, Felix ^b   Zijdenbos, Alex P ^b   Hamel, Edith ^a   Bedell, Barry J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

Alzheimer's disease; Animal model; Beta amyloid; Cortical thickness; Magnetic resonance imaging; Quantitative immunohistochemistry; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, TRANSGENIC;

EID: 84875588646     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.02.005     Document Type: Article

References (48)

1. Badea A., Johnson G.A., Jankowsky J.L. Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease. NeuroImage 2010, 50:416-427.
2. Bakkour A., Morris J.C., Dickerson B.C. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009, 72:1048-1055.
3. Bangerter N.K., Hargreaves B.A., Vasanawala S.S., Pauly J.M., Gold G.E., Nishimura D.G. Analysis of multiple-acquisition SSFP. Magn. Reson. Med. 2004, 51:1038-1047.
4. Beach T.G., Walker R., McGeer E.G. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 1989, 2:420-436.
5. Becker J.A., Hedden T., Carmasin J., Maye J., Rentz D.M., Putcha D., et al. Amyloid-β associated cortical thinning in clinically normal elderly. Ann. Neurol. 2011, 69:1032-1042.
6. Bero A.W., Yan P., Roh J.H., Cirrito J.R., Stewart F.R., Raichle M.E., et al. Neuronal activity regulates the regional vulnerability to amyloid-B deposition. Nat. Neurosci. 2011, 14:750-756.
7. Bero A.W., Bauer A.Q., Stewart F.R., White B.R., Cirrito J.R., Raichle M.E., et al. Bidirectional relationship between functional connectivity and amyloid-β deposition in the mouse brain. J. Neurosci. 2012, 32:4334-4340.
8. Buckner R.L., Sepulcre J., Talukdar T., Krienen F.M., Liu H., Hedden T., et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J. Neurosci. 2009, 29:1860-1873.
9. Chakravarty M.M., Bedell B.J., Zehntner S.P., Evans A.C., Collins D.L. Three-dimensional reconstruction of serial histological mouse brain sections. 5th IEEE International Symposium on Biomedical Imaging, Paris, France, May 14-17 2008.
10. Clark C.M., Schneider J.A., Bedell B.J., Beach T.G., Bilker W.B., Mintun M.A., et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 2011, 305:275-283.
11. Clark C.M., Pontecorvo M.J., Beach T.G., Bedell B.J., Coleman R.E., Doraiswamy P.M., et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. Lancet Neurol. 2012, 11:669-678.
12. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D inter-subject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 1994, 18:192-205.
13. Delatour B., Guegan M., Volk A., Dhenain M. In vivo and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol. Aging 2006, 27:835-847.
14. Desikan R.S., Cabral H.J., Hess C.P., Dillon W.P., Glastonbury C.M., Weiner M.W., et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain 2009, 132:2048-2057.
15. Dickerson B.C., Wolk D.A. Dysexecutive versus amnestic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. J. Neurol. Neurosurg. Psychiatry 2011, 82:45-51.
16. Dickerson B.C., Wolk D.A. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology 2012, 78:84-90.
17. Du A.-T., Schuff N., Kramer J.H., Rosen H.J., Gorno-Tempini M.L., Rankin K., et al. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 2007, 130:1159-1166.
18. Fonov V., Evans A.C., Botteron K., Almli C.R., McKinstry R.C., Collins D.L. Unbiased average age-appropriate atlases for pediatric studies. NeuroImage 2011, 54:313-327.
19. Harris J.A., Devidze N., Verret L., Ho K., Labisky B., Thwin M.T., et al. Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 2010, 68:428-441.
20. He Y., Chen Z., Evans A. Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease. J. Neurosci. 2008, 28:4756-4766.
21. Hébert F., Grand'Maison M., Ho M.-K., Lerch J.P., Hamel E., Bedell B.J. Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer's disease. Neurobiol. Aging 2013, 34:1644-1652.
22. Hutchins J.B., Jefferson V.E. Developmental distribution of platelet-derived growth factor in the mouse central nervous system. Dev. Brain Res. 1992, 67:121-135.
23. Iacono D., O'Brien R., Resnick S.M., Zonderman A.B., Plentikova O., Rudow G., et al. Neuronal hypertrophy in asymptomatic Alzheimer disease. J. Neuropathol. Exp. Neurol. 2008, 67:578-589.
24. Iacono D., Markesbery W.R., Gross M., Pletnikova O., Rudow G., Zandi P., et al. The Nun Study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology 2009, 73:665-673.
25. Lau J.C., Lerch J.P., Sled J.G., Henkelman R.M., Evans A.C., Bedell B.J. Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. NeuroImage 2008, 42:19-27.
26. Lebenberg J., Hérard A.S., Dubois A., Dhenain M., Hantraye P., Delzescaux T. A combination of atlas-based and voxel-wise approaches to analyze metabolic changes in autoradiographic data from Alzheimer's mice. NeuroImage 2011, 57:1447-1457.
27. Leinonen V., Alafuzoff I., Aalto S., Suotunen T., Savolainen S., Någren K., et al. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch. Neurol. 2008, 10:1304-1309.
28. Lerch J.P., Pruessner J.C., Zijdenbos A., Hampel H., Teipel S.J., Evans A.C. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy. Cereb. Cortex 2005, 15:995-1001.
29. Lerch J.P., Carroll J.B., Dorr A., Spring S., Evans A.C., Hayden M.R., et al. Cortical thickness measured from MRI in the YAC128 mouse model of Huntington's disease. NeuroImage 2008, 41:243-251.
30. Li Y., Wang Y., Wu G., Shi F., Zhou L., Lin W., et al. Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features. Neurobiol. Aging 2012, 33:427.e15-427.e30.
31. Lockhart A., Lamb J.R., Osredkar T., Sue L.I., Joyce J.N., Ye L., et al. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain 2007, 130:2607-2615.
32. Maeda J., Ji B., Irie T., Tomiyama T., Maruyama M., Okauchi T., et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J. Neurosci. 2007, 27:10957-10968.
33. Maheswaran S., Barjat H., Rueckert D., Bate S.T., Howlett D.R., Tilling L., et al. Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP×PS1 mice using MRI. Brain Res. 2009, 1270:19-32.
34. 11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS One 2012, 7:e31310.
35. Meyer-Luehmann M., Stalder M., Herzig M.C., Kaeser S.A., Kohler E., Pfeifer M., et al. Extracellular amyloid formation and associated pathology in neural grafts. Nat. Neurosci. 2003, 6:370-377.
36. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., et al. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor Tg mice: synaptotoxicity without plaque formation. J. Neurosci. 2000, 20:4050-4058.
37. 1H MRS in APP/PS1 mice. Neurobiol. Aging 2008, 29:1423-1433.
38. Palop J.J., Jones B., Kekonius L., Chin J., Yu G.Q., Raber J., et al. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9572-9577.
39. Pinheiro J.C., Bates D.M. Mixed-Effects Models in S and S-PLUS 2000, Springer, New York.
40. Querbes O., Aubry F., Pariente J., Lotterie J.-A., Démonet J.-F., Duret V., et al. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 2009, 132:2036-2047.
41. Riudavets M.A., Iacono D., Resnick S.M., O'Brien R., Zonderman A.B., Martin L.J., et al. Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol. Aging 2007, 28:1484-1492.
42. Rosen R.F., Ciliax B.J., Wingo T.S., Gearing M., Dooyema J., Lah J.J., et al. Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol. 2010, 119:221-233.
43. Singh V., Chertkow H., Lerch J., Evans A., Dorr A., Kabani N. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain 2006, 129:2885-2893.
44. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
45. Tong X.-K., Nicolakakis N., Kocharyan A., Hamel E. Vascular remodeling versus amyloid β-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J. Neurosci. 2005, 25:11165-11174.
46. Worsley K.J., Taylor J.E., Carbonell F., Chung M.K., Duerden E., Bernhardt B., et al. SurfStat: a Matlab toolbox for the statistical analysis of univariate and multivariate surface and volumetric data using linear mixed effects models and random field theory. Proceedings of the 15th Annual Meeting of the Organization for Human Brain Mapping, San Francisco, CA, USA 2009.
47. Zehntner S.P., Chakravarty M.M., Bolovan R.J., Chan C., Bedell B.J. Synergistic tissue counterstaining and image segmentation techniques for accurate, quantitative immunohistochemistry. J. Histochem. Cytochem. 2008, 56:873-880.
48. Zijdenbos A.P., Forghani R., Evans A.C. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis. IEEE Trans. Med. Imaging 2002, 21:1280-1291.